Abstract | CONTEXT:
Pseudohypoparathyroidism (PHP) types Ia and Ib, are caused by mutations in GNAS exons 1-13 and GNAS methylation defects, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO and hormone resistance is limited to PTH and, as reported in one paper, TSH. No study addressed the question of GH deficiency in PHP-Ib patients. OBJECTIVES: The objective of the study was to screen patients with clinically diagnosed PHP-Ib for genetic defects and investigate the presence of resistance to TSH and GHRH. PATIENTS/METHODS: We investigated GNAS differential methylation and STX16 microdeletions in genomic DNA from 10 patients with clinical diagnosis of sporadic PHP-Ib, i.e. PTH resistance without AHO. Resistance to GHRH was assessed by GH response to GHRH plus arginine. Thyroid function and ultrasonography were also evaluated. RESULTS: Molecular analysis showed GNAS cluster imprinting defects in all PHP-Ib patients and the first de novo STX16 deletion in one apparently sporadic patient. Subclinical or clinical hypothyroidism due to resistance to TSH was present in nine of 10 patients, whereas a preserved GH response to a GHRH plus arginine test was present in all patients, with one exception. CONCLUSIONS: We report the first molecular analysis of Italian patients with PHP-Ib. Clinical investigation shows that, like PHP-Ia patients, PHP-Ib patients are resistant to TSH, whereas they maintain a normal responsiveness to GHRH, at variance with PHP-Ia patients. These data provide new information on this rare disease and emphasize the clinical heterogeneity of genetic defects within GNAS.
|
Authors | Giovanna Mantovani, Sara Bondioni, Agnès Linglart, Mohamad Maghnie, Mariangela Cisternino, Sabrina Corbetta, Andrea G Lania, Paolo Beck-Peccoz, Anna Spada |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 92
Issue 9
Pg. 3738-42
(Sep 2007)
ISSN: 0021-972X [Print] United States |
PMID | 17595244
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Chromogranins
- Human Growth Hormone
- Insulin-Like Growth Factor I
- Thyrotropin
- Growth Hormone-Releasing Hormone
- Arginine
- GNAS protein, human
- GTP-Binding Protein alpha Subunits, Gs
|
Topics |
- Adolescent
- Adult
- Arginine
(administration & dosage)
- Chromogranins
- DNA Mutational Analysis
- Drug Resistance
(genetics)
- Female
- GTP-Binding Protein alpha Subunits, Gs
(genetics)
- Genetic Testing
- Growth Hormone-Releasing Hormone
(administration & dosage, pharmacology)
- Human Growth Hormone
(metabolism)
- Humans
- Insulin-Like Growth Factor I
(analysis)
- Male
- Middle Aged
- Pseudohypoparathyroidism
(genetics)
- Thyrotropin
(pharmacology)
|